Adjunctive pharmacotherapy

Intervention

1 paper2 findings

  • 1 lab
  • Humans1

Outcomes

2

Time below range

no changein humans1

1 study
  1. Adjunctive pharmacotherapy has no effect on time below range in humans (averaged 2%).

    “Time below range averaged 2% and did not change.”

    Humansin type 1 diabetes using open-source automated insulin delivery systems12 monthsn = 357

    Beyond Insulin Alone: One-Year CGM Outcomes of Adjunctive Incretin-Based and SGLT2 Inhibitors Therapy in Type 1 Diabetes Using Open-Source Automated Insulin Delivery Systems

    ADA Scientific Sessions 2026 abstract5 Jun 2026

More on Time below range

Time in range

upin humans1

1 study
  1. Adjunctive pharmacotherapy increases time in range in humans (from 63% to 73%).

    “Average Time in Range (TIR) rose from 63% at baseline to 73% at 12 months.”

    Humansin type 1 diabetes using open-source automated insulin delivery systems12 monthsn = 357

    Beyond Insulin Alone: One-Year CGM Outcomes of Adjunctive Incretin-Based and SGLT2 Inhibitors Therapy in Type 1 Diabetes Using Open-Source Automated Insulin Delivery Systems

    ADA Scientific Sessions 2026 abstract5 Jun 2026

More on Time in range

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months